Trial intelligence / Profile preview

NUTRIATE: Camicinal for feeding intolerance in critically ill

NCT01934192Phase 2Terminated

Sponsor
GSK
Start
Apr 2014
Primary completion
Jul 2016
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of camicinal in feeding intolerance, sponsored by GSK. Started Apr 2014; status: terminated.

02

Drugs

camicinal
03

Conditions

feeding intolerance

Beyond the preview

Go deeper on NCT01934192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01934192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call